Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.92M Sell
20,682
-8,386
-29% -$2.66M 0.27% 68
2026
Q1
$7.28M Buy
29,068
+1,322
+5% +$293K 0.32% 52
2025
Q4
$4.5M Buy
27,746
+1,373
+5% +$238K 0.2% 79
2025
Q3
$3.98M Buy
26,373
+4,646
+21% +$620K 0.18% 82
2025
Q2
$2.79M Buy
+21,727
New +$2.11M 0.14% 120

Other funds holding VRT

Trilogy Capital's VRT Position: Q2 2026 in Review

Trilogy Capital reduced its Vertiv (VRT) stake by 29% in Q2 2026, selling an estimated $2.66M and leaving 20,682 shares worth $6.92M. The position accounts for 0.27% of the portfolio, ranked #68.

Trilogy Capital first reported a position in VRT in Q2 2025 and has held it in 5 quarters since. The position peaked at $7.28M in Q1 2026. 300 funds tracked by Wall St. Rank hold VRT as of Q2 2026.

  • Trilogy Capital held 20,682 shares of Vertiv worth $6.92M as of Q2 2026.
  • Trilogy Capital sold 8,386 Vertiv shares in Q2 2026, an estimated $2.66M.
  • Vertiv made up 0.27% of Trilogy Capital's portfolio in Q2 2026, its #68 holding.
  • Trilogy Capital first reported a position in Vertiv in Q2 2025 and has held it in 5 quarters since.
  • Trilogy Capital's Vertiv position peaked at $7.28M in Q1 2026.
  • 300 funds tracked by Wall St. Rank held Vertiv as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.